Skip to main content
Equibles
SUPN $48.27 +2.38%
SUPN logo

SUPN · Supernus Pharmaceuticals, Inc.

Track SUPN — free

Use SUPN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about SUPN

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$48.27 +1.12 (+2.38%) At close · Aug 14
Market Cap
$2.81B
Shares
58.13M
All earnings calls

Earnings call · FY2022 Q3

Supernus Pharmaceuticals, Inc. Q3 FY2022 Earnings Call

Supernus Pharmaceuticals, Inc. Q3 FY2022 Earnings Call

Concluded Nov 8, 2022
Nov 8, 2022 0 turns
Period
FY2022 Q3
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $177.35M +19.5% YoY
Diluted EPS $0.03 -92.5% YoY
Net income $1.75M -91.9% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Nov 8, 2022 10-Q report Filed Nov 9, 2022
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)